NCT06117891 2026-04-15
REFINE-IO
Bayer
Recruiting
Clinical Trials
6 trialsNCT07351513 2026-01-20
A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2 Not yet recruiting
NCT07298538 2025-12-23
Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer
Tianjin Medical University Cancer Institute and Hospital
Active not recruiting
NCT05660213 2025-05-20
A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver Cancer
Fudan University
Not yet recruiting
NCT03107416 2025-05-01
Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
NCT01556490 2023-11-08
STOP-HCC
Boston Scientific Corporation
Phase NA Completed